MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 30, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18, 2023 and June 25, 2024, both dates inclusive (the “Class…